1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Pharmaceutical Excipients Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Pharmaceutical Excipients Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Pharmaceutical Excipients Market Regional Analysis
6.2 North America Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)
6.3 North America Pharmaceutical Excipients Market Forecast Analysis
7. North America Pharmaceutical Excipients Market Analysis – by Type
7.1 Bioresorbable Polymers
- 7.1.1 Overview
- 7.1.2 Bioresorbable Polymers: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Lipids and Liposome-Based Formulation
- 7.2.1 Overview
- 7.2.2 Lipids and Liposome-Based Formulation: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Oleochemicals
- 7.3.1 Overview
- 7.3.2 Oleochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Sugars
- 7.4.1 Overview
- 7.4.2 Sugars: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.5 Cellulose
- 7.5.1 Overview
- 7.5.2 Cellulose: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.6 Starches
- 7.6.1 Overview
- 7.6.2 Starches: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.7 Petrochemicals
- 7.7.1 Overview
- 7.7.2 Petrochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.8 Plant Proteins and Polyols and Cyclodextrins
- 7.8.1 Overview
- 7.8.2 Plant Proteins and Polyols and Cyclodextrins: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.9 Inorganic Chemicals
- 7.9.1 Overview
- 7.9.2 Inorganic Chemicals : North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.10
- 7.10.1 Overview
- 7.10.2 : North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Pharmaceutical Excipients Market Analysis – by Clinical Indication
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Metabolic
- 8.2.1 Overview
- 8.2.2 Metabolic: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Infectious Diseases
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Dental
- 8.4.1 Overview
- 8.4.2 Dental: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Ophthalmic
- 8.5.1 Overview
- 8.5.2 Ophthalmic: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Gene Therapies
- 8.6.1 Overview
- 8.6.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Pharmaceutical Excipients Market Analysis – by Functionality
9.1 Coloring Agent and Coating Agent
- 9.1.1 Overview
- 9.1.2 Coloring Agent and Coating Agent: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Sweetener and Flavoring Agents
- 9.2.1 Overview
- 9.2.2 Sweetener and Flavoring Agents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Suspending and Viscosity Agents
- 9.3.1 Overview
- 9.3.2 Suspending and Viscosity Agents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Preservative and Controlled-Release
- 9.4.1 Overview
- 9.4.2 Preservative and Controlled-Release: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Antioxidant and Oil
- 9.5.1 Overview
- 9.5.2 Antioxidant and Oil: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.6 Tablet Filler and Diluents
- 9.6.1 Overview
- 9.6.2 Tablet Filler and Diluents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.7 Binders and Compression Aids and Granulating Agents
- 9.7.1 Overview
- 9.7.2 Binders and Compression Aids and Granulating Agents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Pharmaceutical Excipients Market Analysis – by Application
10.1 Parenteral
- 10.1.1 Overview
- 10.1.2 Parenteral: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Oral Formulations and Tablets
- 10.2.1 Overview
- 10.2.2 Oral Formulations and Tablets: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.3 Capsules
- 10.3.1 Overview
- 10.3.2 Capsules: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.4 Liquid and Injectables
- 10.4.1 Overview
- 10.4.2 Liquid and Injectables: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.5 Physicochemical Excipient-Container Interactions in Prefilled Syringes
- 10.5.1 Overview
- 10.5.2 Physicochemical Excipient-Container Interactions in Prefilled Syringes: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.6 Nutraceuticals and OTC
- 10.6.1 Overview
- 10.6.2 Nutraceuticals and OTC: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.7 Topical
- 10.7.1 Overview
- 10.7.2 Topical: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. North America Pharmaceutical Excipients Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Pharmaceutical Excipients Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 North America Pharmaceutical Excipients Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Pharmaceutical Excipients Market Breakdown, by Type
- 11.2.1.1.2 US: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
- 11.2.1.1.3 US: North America Pharmaceutical Excipients Market Breakdown, by Functionality
- 11.2.1.1.4 US: North America Pharmaceutical Excipients Market Breakdown, by Application
- 11.2.1.2 Canada:
North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Pharmaceutical Excipients Market Breakdown, by Type
- 11.2.1.2.2 Canada: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
- 11.2.1.2.3 Canada: North America Pharmaceutical Excipients Market Breakdown, by Functionality
- 11.2.1.2.4 Canada: North America Pharmaceutical Excipients Market Breakdown, by Application
- 11.2.1.3 Mexico :
North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Type
- 11.2.1.3.2 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
- 11.2.1.3.3 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Functionality
- 11.2.1.3.4 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Application
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Archer-Daniels-Midland Co
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 AshLand Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Avantor Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 BASF SE
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Evonik Industries AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 JRS PHARMA GmbH & Co. KG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 MEGGLE GmbH & Co KG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Roquette Freres SA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 The Dow Chemical Co
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 The Lubrizol Corp
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations